https://medicaex.com/businesswire/avilar-therapeutics-to-present-in-vivo-non-human-primate-data-on-asgpr-targeting-chimeras-atacs-at-the-keystone-symposium-on-targeted-protein-degradation-2/ 2022-11-01T12:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Avilar_logo-9CfROi.jpeg https://medicaex.com/businesswire/castor-expands-platform-capabilities-releases-virtual-visit-feature-to-optimize-the-clinical-trial-experience-for-researchers-and-patients-3/ 2022-11-01T12:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/image18-Oyv09C.jpeg https://medicaex.com/businesswire/orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders-2/ 2022-11-01T12:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/OrsoBio-logo-vertical-Zm3kBR.jpeg https://medicaex.com/businesswire/cybin-announces-scientific-presentation-at-the-5th-annual-neuropsychiatric-psychedelics-drug-development-summit-2/ 2022-11-01T12:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cybin_Primary_Logo_Blue_Final-PJegxh.jpeg https://medicaex.com/businesswire/echosens-presents-robust-research-at-2022-aasld-liver-meeting-noninvasive-fibroscan-technology-recognized-as-critical-component-to-optimize-liver-health-management-2/ 2022-11-01T12:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_echosens_gradient-8mL1Oq.jpeg https://medicaex.com/businesswire/navitus-health-solutions-receives-urac-accreditation-in-pharmacy-benefit-management/ 2022-11-01T12:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_Navitus-Djd29e.jpeg https://medicaex.com/businesswire/nextgen-healthcare-selected-by-cherry-health-to-streamline-operations/ 2022-11-01T12:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/NG_Logo_Final_RGB_300-YN6W5z.jpeg https://medicaex.com/businesswire/applied-uv-announces-new-debt-financings-of-7-5-million-in-aggregate-to-support-growth-2/ 2022-11-01T12:12:11+00:00 https://medicaex.com/businesswire/patient-referral-management-software-market-report-2022-rising-need-for-patient-engagement-driving-growth-researchandmarkets-com/ 2022-11-01T12:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-mBI5eP.jpeg https://medicaex.com/businesswire/applied-uv-announces-new-debt-financings-of-7-5-million-in-aggregate-to-support-growth/ 2022-11-01T12:12:10+00:00 https://medicaex.com/businesswire/echosens-presents-robust-research-at-2022-aasld-liver-meeting-noninvasive-fibroscan-technology-recognized-as-critical-component-to-optimize-liver-health-management/ 2022-11-01T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_echosens_gradient-PMgdE1.jpeg https://medicaex.com/businesswire/amid-national-surge-in-sexually-transmitted-infections-binx-health-announces-launch-of-reagent-rental-program-for-decentralized-rapid-point-of-care-testing-platform-for-chlamydia-and-gonorrhea/ 2022-11-01T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_black-PH2fdo.jpeg https://medicaex.com/businesswire/cerus-corporation-announces-health-canada-approval-for-intercept-blood-system-for-platelets-with-seven-day-storage-2/ 2022-11-01T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/cerus_210x60-WGcI5Q.jpeg https://medicaex.com/businesswire/otc-braces-supports-global-market-report-2022-increasing-prevalence-of-orthopedic-diseases-and-disorders-fuels-growth-researchandmarkets-com/ 2022-11-01T12:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-KpdBCs.jpeg https://medicaex.com/businesswire/cerus-corporation-announces-health-canada-approval-for-intercept-blood-system-for-platelets-with-seven-day-storage/ 2022-11-01T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/cerus_210x60-DdjpBh.jpeg https://medicaex.com/businesswire/castor-expands-platform-capabilities-releases-virtual-visit-feature-to-optimize-the-clinical-trial-experience-for-researchers-and-patients-2/ 2022-11-01T12:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/image18-bPvMm1.jpeg https://medicaex.com/businesswire/orsobio-launches-to-develop-novel-therapies-for-patients-with-severe-metabolic-disorders/ 2022-11-01T12:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/OrsoBio-logo-vertical-BBnVcF.jpeg https://medicaex.com/businesswire/cybin-announces-scientific-presentation-at-the-5th-annual-neuropsychiatric-psychedelics-drug-development-summit/ 2022-11-01T12:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Cybin_Primary_Logo_Blue_Final-EVOjkT.jpeg https://medicaex.com/businesswire/teon-therapeutics-announces-first-patient-treated-in-phase-1-2-clinical-trial-of-tt-816-a-novel-oral-immune-checkpoint-inhibitor-in-patients-with-advanced-solid-tumors/ 2022-11-01T12:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/TEON_Logo_2022-jsp48N.jpeg https://medicaex.com/businesswire/avilar-therapeutics-to-present-in-vivo-non-human-primate-data-on-asgpr-targeting-chimeras-atacs-at-the-keystone-symposium-on-targeted-protein-degradation/ 2022-11-01T12:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Avilar_logo-Znh0kG.jpeg https://medicaex.com/businesswire/castor-expands-platform-capabilities-releases-virtual-visit-feature-to-optimize-the-clinical-trial-experience-for-researchers-and-patients/ 2022-11-01T12:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/image18-RO7l3q.jpeg https://medicaex.com/businesswire/docgo-launches-its-first-app-integrated-with-epic-to-offer-on-demand-access-to-mobile-health-services/ 2022-11-01T12:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/DocGo_Logo_1-HBdxlC.jpeg https://medicaex.com/businesswire/nearly-four-in-five-americans-who-have-used-virtual-primary-care-say-it-helped-them-take-charge-of-their-health/ 2022-11-01T12:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/elv_sm_rgb_c-fQapWB.jpeg https://medicaex.com/businesswire/puretech-to-present-at-the-credit-suisse-31st-annual-healthcare-conference-2/ 2022-11-01T11:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/Credit_Suisse_Healthcare_Conference_2022FINAL-0ke42e.jpeg https://medicaex.com/businesswire/independent-longitudinal-study-finds-caredxs-allosure-detects-early-signs-of-rejection-in-pediatric-kidney-transplant-patients/ 2022-11-01T11:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/CareDx_Logo-ldqVM7.jpeg https://medicaex.com/businesswire/bloombergs-drew-armstrong-joins-endpoints-as-executive-editor-to-lead-expansion-2/ 2022-11-01T11:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/20221027_DrewArmstrong_19783_edit-uIjzn6.jpeg https://medicaex.com/businesswire/receptor-life-sciences-opens-second-investigational-new-drug-ind-application-with-fda-for-rls103-inhaled-dry-powder-cbd-for-the-treatment-of-rapid-epileptic-seizure-termination-rest-2/ 2022-11-01T11:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/Receptor-Primary-SMALL-1a9zwB.jpeg https://medicaex.com/businesswire/castle-biosciences-to-present-at-upcoming-investor-conferences/ 2022-11-01T11:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/CastleLogo2Color-u1bFUO.jpeg https://medicaex.com/businesswire/sonendo-announces-health-canada-regulatory-approval-for-next-generation-gentlewave-g4-system-2/ 2022-11-01T11:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Sonendo-Logo-1920x1080-Color-4wf7Yt.jpeg https://medicaex.com/businesswire/henry-schein-reports-record-non-gaap-third-quarter-2022-diluted-eps-financial-results/ 2022-11-01T11:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/HenrySchein_2000x374-3Iy7z5.jpeg https://medicaex.com/businesswire/sonendo-announces-health-canada-regulatory-approval-for-next-generation-gentlewave-g4-system/ 2022-11-01T11:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Sonendo-Logo-1920x1080-Color-94OXlW.jpeg https://medicaex.com/businesswire/abiomed-announces-second-quarter-revenue-of-266-million-up-11-in-constant-currency-up-7-on-a-reported-basis-year-over-year/ 2022-11-01T11:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/AbioLogo_TAGLINE_COLOR-JoRApo.jpeg https://medicaex.com/businesswire/global-fetal-and-neonatal-monitoring-devices-market-2022-to-2031-featuring-ge-healthcare-fisher-paykel-healthcare-philips-healthcare-and-atom-medical-among-others-researchandmarkets-com/ 2022-11-01T11:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-TSd3uC.jpeg https://medicaex.com/businesswire/global-point-of-care-rapid-diagnostics-market-to-grow-by-12-45-annually-through-2029-researchandmarkets-com-2/ 2022-11-01T11:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-IphzxP.jpeg https://medicaex.com/businesswire/global-point-of-care-rapid-diagnostics-market-to-grow-by-12-45-annually-through-2029-researchandmarkets-com/ 2022-11-01T11:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-pjmqdD.jpeg https://medicaex.com/businesswire/puretech-to-present-at-the-credit-suisse-31st-annual-healthcare-conference/ 2022-11-01T11:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Credit_Suisse_Healthcare_Conference_2022FINAL-Ojp7kS.jpeg https://medicaex.com/businesswire/axcella-reports-third-quarter-financial-results-and-provides-business-update/ 2022-11-01T11:12:08+00:00 https://medicaex.com/businesswire/xeris-biopharma-announces-results-of-the-extended-evaluation-of-recorlev-levoketoconazole-from-the-phase-3-sonics-study-published-in-the-european-journal-of-endocrinology/ 2022-11-01T11:12:08+00:00 https://medicaex.com/businesswire/bloombergs-drew-armstrong-joins-endpoints-as-executive-editor-to-lead-expansion/ 2022-11-01T11:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/20221027_DrewArmstrong_19783_edit-8zNNkT.jpeg https://medicaex.com/businesswire/receptor-life-sciences-opens-second-investigational-new-drug-ind-application-with-fda-for-rls103-inhaled-dry-powder-cbd-for-the-treatment-of-rapid-epileptic-seizure-termination-rest/ 2022-11-01T11:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Receptor-Primary-SMALL-SrPz2j.jpeg https://medicaex.com/businesswire/global-viral-vector-production-market-report-2022-technological-breakthroughs-in-vector-manufacturing-and-a-reliable-pipeline-for-gene-treatments-and-viral-vector-vaccinations-drives-growth-researc-2/ 2022-11-01T10:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-2GqG2m.jpeg https://medicaex.com/businesswire/insulet-recognizes-world-diabetes-day-and-diabetes-awareness-month-throughout-november-3/ 2022-11-01T10:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Katie_Bone_photo_credit_Brooke_Michiels_40b.happycamper-WAHT97.jpeg https://medicaex.com/businesswire/acclaimed-life-sciences-leaders-launch-impact-investment-firm-to-accelerate-health-equity-2/ 2022-11-01T10:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/SyridexBio-Header-RKtFF6.jpeg https://medicaex.com/businesswire/united-therapeutics-corporation-to-present-at-the-credit-suisse-31st-annual-healthcare-conference-2/ 2022-11-01T10:12:11+00:00 https://medicaex.com/businesswire/monroe-capital-supports-qhp-capitals-acquisition-of-autocruitment-2/ 2022-11-01T10:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Monroe_Capital_Logo_RGB-IBbx8Y.jpeg https://medicaex.com/businesswire/forescout-launches-forescout-assist-to-empower-organizations-with-24-7-threat-detection-investigation-and-response-expertise-and-capabilities/ 2022-11-01T10:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/78bb5110-73fe-4ec9-990c-4b7afbe55923-ZW1wgD.jpeg https://medicaex.com/businesswire/insulet-recognizes-world-diabetes-day-and-diabetes-awareness-month-throughout-november-2/ 2022-11-01T10:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Katie_Bone_photo_credit_Brooke_Michiels_40b.happycamper-Ez9Nx5.jpeg https://medicaex.com/businesswire/insulet-recognizes-world-diabetes-day-and-diabetes-awareness-month-throughout-november/ 2022-11-01T10:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Katie_Bone_photo_credit_Brooke_Michiels_40b.happycamper-b63XLb.jpeg https://medicaex.com/businesswire/acclaimed-life-sciences-leaders-launch-impact-investment-firm-to-accelerate-health-equity/ 2022-11-01T10:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/SyridexBio-Header-GVJpxI.jpeg https://medicaex.com/businesswire/united-therapeutics-corporation-to-present-at-the-credit-suisse-31st-annual-healthcare-conference/ 2022-11-01T10:12:04+00:00 https://medicaex.com/businesswire/monroe-capital-supports-qhp-capitals-acquisition-of-autocruitment/ 2022-11-01T10:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Monroe_Capital_Logo_RGB-4NGuxQ.jpeg https://medicaex.com/businesswire/global-viral-vector-production-market-report-2022-technological-breakthroughs-in-vector-manufacturing-and-a-reliable-pipeline-for-gene-treatments-and-viral-vector-vaccinations-drives-growth-researc/ 2022-11-01T10:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-KXztKY.jpeg https://medicaex.com/businesswire/memo-therapeutics-ag-and-ono-pharmaceutical-enter-antibody-discovery-partnership-for-immuno-oncology-targets-2/ 2022-11-01T08:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/memoAG_logo_green_dark-i2xmrS.jpeg https://medicaex.com/businesswire/oui-inc-the-japanese-startup-of-a-smartphone-based-ophthalmic-diagnostic-medical-device-wins-first-prize-at-aea2022-innovation-awards/ 2022-11-01T08:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/AEA2022_Winner-wP0hdg.jpeg https://medicaex.com/businesswire/memo-therapeutics-ag-and-ono-pharmaceutical-enter-antibody-discovery-partnership-for-immuno-oncology-targets/ 2022-11-01T08:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/memoAG_logo_green_dark-X3Ms0W.jpeg https://medicaex.com/businesswire/tetris-pharma-launches-ogluo-in-germany-3/ 2022-11-01T06:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Tetris_Corporate_Logo-YlV0Dg.jpeg https://medicaex.com/businesswire/tetris-pharma-launches-ogluo-in-germany-2/ 2022-11-01T06:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Tetris_Corporate_Logo-5jvRaP.jpeg https://medicaex.com/businesswire/tetris-pharma-launches-ogluo-in-germany/ 2022-11-01T06:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Tetris_Corporate_Logo-9oKEQ6.jpeg https://medicaex.com/businesswire/eucure-biopharma-a-subsidiary-of-biocytogen-announces-partnership-with-isu-abxis-for-the-development-of-tri-specific-antibodies-using-yh003-antibody-sequence-3/ 2022-11-01T00:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo250-T7OLUp.jpeg https://medicaex.com/businesswire/eucure-biopharma-a-subsidiary-of-biocytogen-announces-partnership-with-isu-abxis-for-the-development-of-tri-specific-antibodies-using-yh003-antibody-sequence-4/ 2022-11-01T00:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Biocytogen27s_LOGO-FUsaot.jpeg https://medicaex.com/businesswire/eucure-biopharma-a-subsidiary-of-biocytogen-announces-partnership-with-isu-abxis-for-the-development-of-tri-specific-antibodies-using-yh003-antibody-sequence/ 2022-11-01T00:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo250-NkM6tC.jpeg https://medicaex.com/businesswire/eucure-biopharma-a-subsidiary-of-biocytogen-announces-partnership-with-isu-abxis-for-the-development-of-tri-specific-antibodies-using-yh003-antibody-sequence-2/ 2022-11-01T00:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Biocytogen27s_LOGO-UynzUA.jpeg https://medicaex.com/businesswire/orum-therapeutics-announces-first-patient-dosed-in-phase-1-clinical-trial-of-orm-5029-in-development-to-treat-her2-expressing-advanced-solid-tumors-2/ 2022-10-31T23:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/ORUM2BLOGO2B-2BPNG-eJWomr.jpeg https://medicaex.com/businesswire/adicet-bio-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/ 2022-10-31T23:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/adicet_logo_500x300_2800229_2800429-UOhaWR.jpeg https://medicaex.com/businesswire/orum-therapeutics-announces-first-patient-dosed-in-phase-1-clinical-trial-of-orm-5029-in-development-to-treat-her2-expressing-advanced-solid-tumors/ 2022-10-31T23:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/ORUM2BLOGO2B-2BPNG-Zmz0QL.jpeg https://medicaex.com/businesswire/reata-pharmaceuticals-inc-to-report-third-quarter-2022-financial-results-and-to-provide-an-update-on-clinical-development-programs-on-november-8-2022-2/ 2022-10-31T21:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/REATA_PHARM_Normal_LOGO-qM9LB5.jpeg https://medicaex.com/businesswire/avivagen-inc-announces-closing-of-second-tranche-of-a-private-placement-of-shares/ 2022-10-31T21:12:09+00:00 https://medicaex.com/businesswire/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business-2/ 2022-10-31T21:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/PersonalisLogo-RGB-no-tagline-5IJenz.jpeg https://medicaex.com/businesswire/nanthealth-to-report-2022-third-quarter-financial-results-and-host-conference-call-on-thursday-november-3/ 2022-10-31T21:12:07+00:00 https://medicaex.com/businesswire/reata-pharmaceuticals-inc-to-report-third-quarter-2022-financial-results-and-to-provide-an-update-on-clinical-development-programs-on-november-8-2022/ 2022-10-31T21:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/REATA_PHARM_Normal_LOGO-35AJ4I.jpeg https://medicaex.com/businesswire/labcorp-to-speak-at-the-credit-suisse-31st-annual-healthcare-conference/ 2022-10-31T21:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Labcorp_Logo_Horizontal_Color_RGB-BKrOlj.jpeg https://medicaex.com/businesswire/personalis-grows-leadership-team-with-appointment-of-christopher-hall-as-senior-vice-president-and-head-diagnostics-business/ 2022-10-31T21:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/PersonalisLogo-RGB-no-tagline-Q9avfQ.jpeg https://medicaex.com/businesswire/amneal-expands-leadership-team-with-appointment-of-senior-leaders-in-quality-and-regulatory-3/ 2022-10-31T20:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/amneallogo-zzmBK5.jpeg https://medicaex.com/businesswire/pear-therapeutics-to-issue-third-quarter-2022-financial-results-on-monday-november-14-2022-2/ 2022-10-31T20:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-Pear-Therapeutics-Final-YAEDsb.jpeg https://medicaex.com/businesswire/xencor-to-host-third-quarter-2022-financial-results-webcast-and-conference-call-on-november-7-2022-2/ 2022-10-31T20:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Xencor_logo_BW-83P17t.jpeg https://medicaex.com/businesswire/axonics-reports-third-quarter-2022-financial-results-2/ 2022-10-31T20:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Axonics_Logo_-_Color-TT1sc5.jpeg https://medicaex.com/businesswire/hologic-announces-financial-results-for-fourth-quarter-of-fiscal-2022-2/ 2022-10-31T20:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Hologic_Logo_no_tagline_PMS2756-brFnfM.jpeg https://medicaex.com/businesswire/hologic-announces-financial-results-for-fourth-quarter-of-fiscal-2022/ 2022-10-31T20:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Hologic_Logo_no_tagline_PMS2756-VtPSbk.jpeg https://medicaex.com/businesswire/angiodynamics-announces-first-patient-enrolled-in-apex-av-study-assessing-alphavac-f1885-pe-system-in-treatment-of-pulmonary-embolism-2/ 2022-10-31T20:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/ANGO_-_Logo-7KSd47.jpeg https://medicaex.com/businesswire/angiodynamics-announces-first-patient-enrolled-in-apex-av-study-assessing-alphavac-f1885-pe-system-in-treatment-of-pulmonary-embolism/ 2022-10-31T20:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/ANGO_-_Logo-MMA3ZL.jpeg https://medicaex.com/businesswire/transcat-reports-strong-second-quarter-results-on-19-service-revenue-growth-2/ 2022-10-31T20:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Transcat_Logo-3diZvU.jpeg https://medicaex.com/businesswire/amneal-expands-leadership-team-with-appointment-of-senior-leaders-in-quality-and-regulatory-2/ 2022-10-31T20:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/amneallogo-AmP1B6.jpeg https://medicaex.com/businesswire/pear-therapeutics-to-issue-third-quarter-2022-financial-results-on-monday-november-14-2022/ 2022-10-31T20:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-Pear-Therapeutics-Final-LOvt2h.jpeg https://medicaex.com/businesswire/xencor-to-host-third-quarter-2022-financial-results-webcast-and-conference-call-on-november-7-2022/ 2022-10-31T20:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Xencor_logo_BW-TuHMTp.jpeg https://medicaex.com/businesswire/axonics-reports-third-quarter-2022-financial-results/ 2022-10-31T20:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Axonics_Logo_-_Color-1PVSn9.jpeg https://medicaex.com/businesswire/transcat-reports-strong-second-quarter-results-on-19-service-revenue-growth/ 2022-10-31T20:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Transcat_Logo-TaGhPT.jpeg https://medicaex.com/businesswire/amneal-expands-leadership-team-with-appointment-of-senior-leaders-in-quality-and-regulatory/ 2022-10-31T20:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/amneallogo-REIVcV.jpeg https://medicaex.com/businesswire/talon-introduces-new-chief-revenue-officer-dan-mayton/ 2022-10-31T19:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/TALON_Logo_Color-aGpR80.jpeg https://medicaex.com/businesswire/cell-reprogramming-market-share-size-trends-industry-analysis-report-by-technology-by-application-by-end-use-by-region-segment-forecast-2022-2030-researchandmarkets-com-3/ 2022-10-31T18:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-g76tz4.jpeg https://medicaex.com/businesswire/reditus-to-cease-operations/ 2022-10-31T18:12:08+00:00 https://medicaex.com/businesswire/altasciences-receives-accreditation-from-college-of-american-pathologists-2/ 2022-10-31T18:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Altasciences_Gradient_V_RGB-q3uKQ9.jpeg https://medicaex.com/businesswire/cell-reprogramming-market-share-size-trends-industry-analysis-report-by-technology-by-application-by-end-use-by-region-segment-forecast-2022-2030-researchandmarkets-com-2/ 2022-10-31T18:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Pbic25.jpeg https://medicaex.com/businesswire/global-osmometers-market-report-2022-to-2030-rise-in-prevalence-of-electrolyte-disorders-launch-of-innovative-products-by-key-players-and-expansion-of-healthcare-companies-is-driving-growth-resear/ 2022-10-31T18:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-uqwqHl.jpeg https://medicaex.com/businesswire/cell-reprogramming-market-share-size-trends-industry-analysis-report-by-technology-by-application-by-end-use-by-region-segment-forecast-2022-2030-researchandmarkets-com/ 2022-10-31T18:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-GZpnO1.jpeg https://medicaex.com/businesswire/altasciences-receives-accreditation-from-college-of-american-pathologists/ 2022-10-31T18:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Altasciences_Gradient_V_RGB-nCnc81.jpeg https://medicaex.com/businesswire/global-ultrasound-image-analysis-software-market-report-to-2027-featuring-koninklijke-philips-merge-healthcare-mim-software-and-mirada-medical-among-others-researchandmarkets-com-3/ 2022-10-31T17:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-5LR06u.jpeg https://medicaex.com/businesswire/global-ultrasound-image-analysis-software-market-report-to-2027-featuring-koninklijke-philips-merge-healthcare-mim-software-and-mirada-medical-among-others-researchandmarkets-com-2/ 2022-10-31T17:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-8wgtBX.jpeg https://medicaex.com/businesswire/the-worldwide-over-the-counter-braces-support-industry-is-expected-to-reach-1-6-billion-by-2027-researchandmarkets-com/ 2022-10-31T17:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-XaZBzR.jpeg https://medicaex.com/businesswire/global-ultrasound-image-analysis-software-market-report-to-2027-featuring-koninklijke-philips-merge-healthcare-mim-software-and-mirada-medical-among-others-researchandmarkets-com/ 2022-10-31T17:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-jeyBny.jpeg https://medicaex.com/businesswire/euroapi-to-reach-500-kg-peptide-and-oligonucleotide-capacity-per-year-in-frankfurt-by-2025/ 2022-10-31T17:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/euroAPI_Logo_RVB_digital-nPj55O.jpeg https://medicaex.com/businesswire/global-cell-free-protein-expression-market-report-2022-increasing-rd-in-proteomics-and-genomics-drives-growth-researchandmarkets-com/ 2022-10-31T17:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-m0HoUX.jpeg https://medicaex.com/businesswire/insights-on-the-air-compressor-filter-compressed-air-dryer-global-market-to-2027-increasing-use-in-pharmaceutical-packaging-presents-opportunities-researchandmarkets-com/ 2022-10-31T17:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-QEcDZg.jpeg https://medicaex.com/businesswire/oncoprecision-raises-3-3m-seed-funding-to-improve-cancer-patient-outcomes-and-drug-development-efforts-with-patient-micro-avatars-2/ 2022-10-31T16:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/OncoPrecision_-_Iso_-_Positive_Transparent_28229-GLJc84.jpeg https://medicaex.com/businesswire/2022-fda-good-clinical-practice-guide-the-one-stop-resource-for-clinical-trial-regulations-and-guidelines-researchandmarkets-com-3/ 2022-10-31T16:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-ZPBomL.jpeg https://medicaex.com/businesswire/global-diagnostic-imaging-services-market-report-2022-growing-awareness-about-early-disease-detection-and-the-widening-scope-of-clinical-applications-presents-opportunities-researchandmarkets-com-3/ 2022-10-31T16:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-1lEfQw.jpeg https://medicaex.com/businesswire/global-diagnostic-imaging-services-market-report-2022-growing-awareness-about-early-disease-detection-and-the-widening-scope-of-clinical-applications-presents-opportunities-researchandmarkets-com-2/ 2022-10-31T16:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-j3VSHb.jpeg https://medicaex.com/businesswire/clario-selects-transperfect-technology-to-reduce-translation-turnaround-times-by-30/ 2022-10-31T16:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/TP_Stacked_RGB-Q6ypax.jpeg https://medicaex.com/businesswire/global-diagnostic-imaging-services-market-report-2022-growing-awareness-about-early-disease-detection-and-the-widening-scope-of-clinical-applications-presents-opportunities-researchandmarkets-com/ 2022-10-31T16:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-4x6nHy.jpeg https://medicaex.com/businesswire/2022-fda-good-clinical-practice-guide-the-one-stop-resource-for-clinical-trial-regulations-and-guidelines-researchandmarkets-com-2/ 2022-10-31T16:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-2y3WEb.jpeg https://medicaex.com/businesswire/2022-fda-good-clinical-practice-guide-the-one-stop-resource-for-clinical-trial-regulations-and-guidelines-researchandmarkets-com/ 2022-10-31T16:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-vv0QwZ.jpeg https://medicaex.com/businesswire/drug-enforcement-administration-dea-controlled-substances-module-and-handbook-2022-guide-to-manufacturing-storing-securing-shipping-distributing-importing-exporting-and-disposal-researchand/ 2022-10-31T16:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-3s3KOx.jpeg https://medicaex.com/businesswire/oncoprecision-raises-3-3m-seed-funding-to-improve-cancer-patient-outcomes-and-drug-development-efforts-with-patient-micro-avatars/ 2022-10-31T16:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/OncoPrecision_-_Iso_-_Positive_Transparent_28229-8ctnmu.jpeg https://medicaex.com/businesswire/global-brain-monitoring-market-report-2022-to-2027-players-include-general-electric-integra-lifesciences-koninklijke-philips-masimo-and-medtronic-researchandmarkets-com/ 2022-10-31T15:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-GgF8hC.jpeg https://medicaex.com/businesswire/global-digital-health-market-report-to-2027-key-players-include-allscripts-healthcare-solution-cerner-cisco-systems-and-koninklijke-philips-researchandmarkets-com-2/ 2022-10-31T15:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-UjiN9R.jpeg https://medicaex.com/businesswire/timelymd-named-fast-tech-winner-in-tech-titans-awards-2/ 2022-10-31T15:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/10/TimelyMD-Logo-Horz_28129-Bade2k.jpeg https://medicaex.com/businesswire/global-digital-health-market-report-to-2027-key-players-include-allscripts-healthcare-solution-cerner-cisco-systems-and-koninklijke-philips-researchandmarkets-com/ 2022-10-31T15:12:02+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-FT0jbR.jpeg https://medicaex.com/businesswire/timelymd-named-fast-tech-winner-in-tech-titans-awards/ 2022-10-31T15:12:02+00:00 https://medicaex.com/wp-content/uploads/2022/10/TimelyMD-Logo-Horz_28129-mdTuSL.jpeg https://medicaex.com/businesswire/hevolution-foundation-announces-pilot-grants-program-for-top-healthspan-related-research-in-the-united-states/ 2022-10-31T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/10/HEVOLUTION_Logo_White_Background_2800229-4DbOzW.jpeg https://medicaex.com/businesswire/u-s-real-world-evidence-solutions-market-report-2022-growing-adoption-of-rwe-in-drug-development-and-commercialization-to-reshape-sector-researchandmarkets-com-2/ 2022-10-31T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-6vDT5M.jpeg https://medicaex.com/businesswire/loulou-foundation-announces-first-patient-in-for-candid-observational-study-on-cdkl5-deficiency-disorder/ 2022-10-31T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/10/LLF_logo_no_background-I7kDwg.jpeg https://medicaex.com/businesswire/siemens-healthineers-and-university-of-miami-health-system-enter-value-partnership-agreement-to-transform-healthcare-2/ 2022-10-31T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/10/sh_logo_rgb-9e5v0T.jpeg https://medicaex.com/businesswire/cleerly-introduces-proxy-solution-to-improve-heart-disease-imaging-workflows/ 2022-10-31T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/10/Cleerly_Logo-LscZyb.jpeg https://medicaex.com/businesswire/siemens-healthineers-and-university-of-miami-health-system-enter-value-partnership-agreement-to-transform-healthcare/ 2022-10-31T14:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/10/sh_logo_rgb-RfDchy.jpeg https://medicaex.com/businesswire/intravenous-iv-solutions-global-market-report-2022-alarming-rise-in-diabetes-incidence-worldwide-fuels-growth-researchandmarkets-com-3/ 2022-10-31T14:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-Gu9a0C.jpeg https://medicaex.com/businesswire/intravenous-iv-solutions-global-market-report-2022-alarming-rise-in-diabetes-incidence-worldwide-fuels-growth-researchandmarkets-com-2/ 2022-10-31T14:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-fQWLEn.jpeg https://medicaex.com/businesswire/cleveland-diagnostics-announces-the-publication-of-two-major-isopsa-studies-3/ 2022-10-31T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/10/CDX_logo-KuKsIQ.jpeg https://medicaex.com/businesswire/sagimet-biosciences-announces-late-breaking-oral-and-poster-presentations-for-denifanstat-tvb-2640-a-first-in-class-fatty-acid-synthase-inhibitor-in-nash-at-aaslds-the-liver-meeting-2/ 2022-10-31T13:12:12+00:00 https://medicaex.com/businesswire/diamedica-therapeutics-to-present-at-credit-suisse-31st-annual-healthcare-conference-2/ 2022-10-31T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/10/DiaMedica-Logo-white-background-kjEj9x.jpeg https://medicaex.com/businesswire/bio-rad-to-participate-in-fireside-chat-during-credit-suisses-31st-annual-healthcare-conference-3/ 2022-10-31T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/10/Logo_RGB_on_transpar-chOkS4.jpeg https://medicaex.com/businesswire/genetic-toxicology-testing-market-report-2022-increasing-use-of-pharmacogenomics-and-personalized-medicines-drives-growth-researchandmarkets-com/ 2022-10-31T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-TvQ4bs.jpeg https://medicaex.com/businesswire/align-technology-announces-200-million-accelerated-stock-repurchase-agreement-under-its-1-billion-repurchase-program-2/ 2022-10-31T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/10/Align_tagline_vertical_RGB_charcoal_2c-7oLgXF.jpeg https://medicaex.com/businesswire/heru-supercharges-executive-leadership-team-with-fred-drasner-ron-williams-and-chris-dewey-to-drive-next-phase-of-growth/ 2022-10-31T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/10/heru_logo-5R8U3k.jpeg https://medicaex.com/businesswire/omnivision-and-adaptivendo-partner-to-provide-a-unified-platform-for-hybrid-and-single-use-flexible-endoscopes-2/ 2022-10-31T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/10/OMNIVISION-CMYK-LOGO-SILVER-BLACK-T9TpYr.jpeg https://medicaex.com/businesswire/mass-general-brigham-implements-dexcare-to-support-care-integration-and-advance-digital-health-2/ 2022-10-31T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/10/dexcare_logo_color_2800229-RLTPpl.jpeg https://medicaex.com/businesswire/accenture-federal-services-awarded-prime-role-on-650m-department-of-veterans-affairs-healthcare-innovation-contract-2/ 2022-10-31T13:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/10/ShawnRoman-aGxXJM.jpeg https://medicaex.com/businesswire/global-microarray-market-report-2022-featuring-geron-epic-sciences-inc-genexine-commence-bio-and-vitatex-inc-researchandmarkets-com/ 2022-10-31T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-rzJkLM.jpeg https://medicaex.com/businesswire/cleveland-diagnostics-announces-the-publication-of-two-major-isopsa-studies-2/ 2022-10-31T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/10/CDX_logo-rxA10P.jpeg https://medicaex.com/businesswire/align-technology-announces-200-million-accelerated-stock-repurchase-agreement-under-its-1-billion-repurchase-program/ 2022-10-31T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/10/Align_tagline_vertical_RGB_charcoal_2c-0M422S.jpeg https://medicaex.com/businesswire/omnivision-and-adaptivendo-partner-to-provide-a-unified-platform-for-hybrid-and-single-use-flexible-endoscopes/ 2022-10-31T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/10/OMNIVISION-CMYK-LOGO-SILVER-BLACK-MTVzV8.jpeg https://medicaex.com/businesswire/zoll-awarded-diagnostic-and-interventional-cardiology-catheter-agreement-with-premier-inc-for-therox-supersaturated-oxygen-therapy/ 2022-10-31T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/10/TherOx_Release_10-31-ZS852T.jpeg https://medicaex.com/businesswire/bio-rad-to-participate-in-fireside-chat-during-credit-suisses-31st-annual-healthcare-conference-2/ 2022-10-31T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/10/Logo_RGB_on_transpar-j6vOE7.jpeg https://medicaex.com/businesswire/mass-general-brigham-implements-dexcare-to-support-care-integration-and-advance-digital-health/ 2022-10-31T13:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/10/dexcare_logo_color_2800229-rxzoPn.jpeg https://medicaex.com/businesswire/accenture-federal-services-awarded-prime-role-on-650m-department-of-veterans-affairs-healthcare-innovation-contract/ 2022-10-31T13:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/10/ShawnRoman-9zRlXz.jpeg https://medicaex.com/businesswire/altoida-to-present-at-upcoming-industry-conferences-2/ 2022-10-31T12:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-blue_28129-yrdXno.jpeg https://medicaex.com/businesswire/lineage-cell-therapeutics-appoints-jill-howe-as-chief-financial-officer-2/ 2022-10-31T12:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/10/LINEAGE_SCREEN_JPEG_1800x360-Yn7XyR.jpeg https://medicaex.com/businesswire/cognito-therapeutics-to-present-clinical-data-evaluating-gamma-frequency-neuromodulation-in-alzheimers-disease-at-2022-ctad-conference-2/ 2022-10-31T12:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/10/full_-_gardient_-_dark_text402x_28429_28429_28129_28229-9l4Dx8.jpeg https://medicaex.com/businesswire/aulos-bioscience-announces-fda-clearance-of-ind-application-for-au-007-a-novel-immunotherapy-for-the-treatment-of-solid-tumors/ 2022-10-31T12:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/10/Aulos_Logo_2022FEB22-nozUPi.jpeg https://medicaex.com/businesswire/lantern-pharma-to-report-third-quarter-2022-operating-financial-results-on-november-7-2022-at-430-p-m-et-2/ 2022-10-31T12:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/10/Lantern_Logo_Stacked-mSRId8.jpeg https://medicaex.com/businesswire/impella-rp-flex-with-smartassist-receives-fda-approval-to-treat-right-heart-failure-2/ 2022-10-31T12:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/10/Abiomed_RP_Flex_with_SmartAssist-lUP5Aa-rotated.jpeg https://medicaex.com/businesswire/global-sepsis-diagnostic-market-report-to-2030-featuring-biomerieux-thermo-fisher-scientific-abbott-laboratories-and-bruker-among-others-researchandmarkets-com/ 2022-10-31T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-GWLdg1.jpeg https://medicaex.com/businesswire/insights-on-the-smart-insulin-pens-global-market-to-2030-surging-incidence-of-diabetic-patients-coupled-with-the-cost-effective-nature-of-insulin-pens-is-driving-growth-researchandmarkets-com/ 2022-10-31T12:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-7h1DlK.jpeg https://medicaex.com/businesswire/impella-rp-flex-with-smartassist-receives-fda-approval-to-treat-right-heart-failure/ 2022-10-31T12:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/10/Abiomed_RP_Flex_with_SmartAssist-fOKymL-rotated.jpeg https://medicaex.com/businesswire/real-world-clinical-utility-study-published-in-cancer-investigation-demonstrates-the-impact-of-decisiondx-scc-test-results-in-guiding-risk-aligned-care-for-patients-with-cutaneous-squamous-cell/ 2022-10-31T11:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/10/CastleLogo2Color-KZNigK.jpeg https://medicaex.com/businesswire/bristol-myers-squibb-announces-positive-topline-results-of-phase-3-commands-trial-2/ 2022-10-31T11:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/10/BMS_LOGO-jn9bWO.jpeg https://medicaex.com/businesswire/thermo-fisher-scientific-continues-to-execute-proven-capital-deployment-strategy-4/ 2022-10-31T11:12:12+00:00 https://medicaex.com/businesswire/thermo-fisher-scientific-to-acquire-the-binding-site-group-3/ 2022-10-31T11:12:12+00:00 https://medicaex.com/businesswire/concert-pharmaceuticals-to-report-third-quarter-2022-results-on-november-7-2022-2/ 2022-10-31T11:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/10/concert_logo_r_1976x566-BWjGHz.jpeg https://medicaex.com/businesswire/thermo-fisher-scientific-continues-to-execute-proven-capital-deployment-strategy-3/ 2022-10-31T11:12:10+00:00 https://medicaex.com/businesswire/thermo-fisher-scientific-to-acquire-the-binding-site-group-2/ 2022-10-31T11:12:10+00:00 https://medicaex.com/businesswire/verge-genomics-initiates-first-in-human-dosing-in-phase-1-trial-of-vrg50635-a-novel-therapeutic-for-amyotrophic-lateral-sclerosis/ 2022-10-31T11:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/10/Verge_Logo_28129-dCvF5X.jpeg https://medicaex.com/businesswire/thermo-fisher-scientific-continues-to-execute-proven-capital-deployment-strategy-2/ 2022-10-31T11:12:09+00:00 https://medicaex.com/businesswire/thermo-fisher-scientific-to-acquire-the-binding-site-group/ 2022-10-31T11:12:09+00:00 https://medicaex.com/businesswire/turnstone-biologics-announces-fda-clearance-of-ind-for-tidal-01-a-next-generation-til-therapy-for-solid-tumors-2/ 2022-10-31T10:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/10/TSTN_Logo_Twitter-ydxDdk.jpeg https://medicaex.com/businesswire/united-therapeutics-announces-top-line-data-from-the-expedite-study-of-remodulin-induction-prior-to-orenitram-therapy-2/ 2022-10-31T10:12:11+00:00 https://medicaex.com/businesswire/epic-bio-presents-first-data-supporting-persistent-and-tunable-gene-activation-using-transient-delivery-3/ 2022-10-31T10:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/10/EpicBioCMYK300dpi-iEm2aH.jpeg https://medicaex.com/businesswire/epic-bio-presents-first-data-supporting-persistent-and-tunable-gene-activation-using-transient-delivery-2/ 2022-10-31T10:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/10/EpicBioCMYK300dpi-IqOEIz.jpeg https://medicaex.com/businesswire/lee-ventus-long-life-pump-exceeds-1-trillion-cycles/ 2022-10-31T10:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/10/The_LT_Series_Pump-Va5BrL.jpeg https://medicaex.com/businesswire/ochre-bio-announces-participation-in-upcoming-conferences-2/ 2022-10-31T08:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/10/ochre_bio_logo-q268f3.jpeg https://medicaex.com/businesswire/syngenta-group-honored-as-top-agriculture-employer-for-sixth-consecutive-year-in-2022-science-magazine-survey-ranked-no-5-overall/ 2022-10-31T07:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/10/01_Science_Mag_Top_Employer-Still-withlogo-d0IYa6.jpeg https://medicaex.com/businesswire/innocare-announces-first-adolescent-patient-dosed-in-clinical-trial-of-pan-trk-inhibitor-icp-723-in-china-2/ 2022-10-31T07:12:09+00:00 https://medicaex.com/businesswire/aurinia-pharmaceuticals-to-release-third-quarter-2022-financial-and-operational-results-on-november-3-2022-2/ 2022-10-28T22:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/10/aurina_logo-FzsMlC.jpeg https://medicaex.com/businesswire/global-medical-equipment-maintenance-market-to-reach-88-5-billion-by-2027-researchandmarkets-com/ 2022-10-28T17:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-Gk2ewt.jpeg https://medicaex.com/businesswire/world-infectious-respiratory-disease-diagnostics-market-analysis-report-2022-2030-increasing-focus-on-introducing-multiplex-pcr-adoption-of-self-testing-products-and-point-of-care-products-re-2/ 2022-10-28T17:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-pQwFA7.jpeg https://medicaex.com/businesswire/world-infectious-respiratory-disease-diagnostics-market-analysis-report-2022-2030-increasing-focus-on-introducing-multiplex-pcr-adoption-of-self-testing-products-and-point-of-care-products-re/ 2022-10-28T17:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-51NwqV.jpeg https://medicaex.com/businesswire/global-research-antibodies-market-analysis-report-2022-2030-lucrative-opportunities-in-growing-demand-for-personalized-medicine-and-rising-focus-on-biomarker-discovery-researchandmarkets-com-2/ 2022-10-28T16:12:26+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-YPbdwt.jpeg https://medicaex.com/businesswire/cellular-health-screening-market-report-2022-rise-in-the-adoption-of-telomere-performance-programs-driving-growth-researchandmarkets-com/ 2022-10-28T16:12:26+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-a407XY.jpeg https://medicaex.com/businesswire/global-pulse-oximeters-market-report-2022-increasing-prevalence-of-congenital-heart-disease-chd-in-children-drives-growth-researchandmarkets-com/ 2022-10-28T16:12:21+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-sdhjst.jpeg https://medicaex.com/businesswire/south-central-america-diagnostic-labs-market-report-2022-increasing-use-of-point-of-care-diagnostics-augments-growth-researchandmarkets-com-2/ 2022-10-28T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-tX0pRJ.jpeg https://medicaex.com/businesswire/biocom-california-announces-seventh-annual-life-science-catalyst-award-winners/ 2022-10-28T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/10/BiocomCaliforniaLogo_Primary-2-lKSxio.jpeg https://medicaex.com/businesswire/global-animal-imaging-market-report-2022-growing-rates-of-zoonotic-disease-boosting-sector-researchandmarkets-com/ 2022-10-28T15:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-bXOivo.jpeg https://medicaex.com/businesswire/kimball-electronics-inc-announces-details-for-its-annual-meeting-of-share-owners-2/ 2022-10-28T15:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/10/Kimball_Electronics_Logo-zfazr7.jpeg https://medicaex.com/businesswire/south-central-america-diagnostic-labs-market-report-2022-increasing-use-of-point-of-care-diagnostics-augments-growth-researchandmarkets-com/ 2022-10-28T15:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-x1CSr2.jpeg https://medicaex.com/businesswire/kimball-electronics-inc-announces-details-for-its-annual-meeting-of-share-owners/ 2022-10-28T15:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/10/Kimball_Electronics_Logo-iLVOvY.jpeg https://medicaex.com/businesswire/immunogen-presents-retrospective-analysis-of-extended-treatment-benefit-from-multiple-trials-of-mirvetuximab-soravtansine-in-ovarian-cancer-at-esgo/ 2022-10-28T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/10/imgnlogo-5Pq1Sj.jpeg https://medicaex.com/businesswire/genmab-announces-submissions-of-regulatory-applications-for-epcoritamab-duobody-cd3xcd20-for-the-treatment-of-relapsed-refractory-large-b-cell-lymphoma-lbcl-and-diffuse-large-b-cell-lymphoma-2/ 2022-10-28T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/10/Genmab_Logo_Color_RGB-tPrHNt.jpeg https://medicaex.com/businesswire/global-diagnostic-biomarker-market-research-analysis-report-2022-2028-active-funding-by-research-institutes-creating-growth-opportunities-researchandmarkets-com-2/ 2022-10-28T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-zTYEQZ.jpeg https://medicaex.com/businesswire/worldwide-digital-vaccine-industry-to-2027-growing-technological-advancements-are-driving-the-market-researchandmarkets-com-2/ 2022-10-28T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-7YVQ8k.jpeg https://medicaex.com/businesswire/global-diagnostic-biomarker-market-research-analysis-report-2022-2028-active-funding-by-research-institutes-creating-growth-opportunities-researchandmarkets-com/ 2022-10-28T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-VY9ZSg.jpeg https://medicaex.com/businesswire/feops-secures-additional-capital-from-the-eic-fund/ 2022-10-28T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/10/FEOPS_logo_transp_300dpi-brotnH.jpeg https://medicaex.com/businesswire/walgreens-boots-alliance-appoints-bryan-c-hanson-to-board-of-directors/ 2022-10-28T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/10/Bryan_Hanson-Ro8JCj.jpeg https://medicaex.com/businesswire/worldwide-digital-vaccine-industry-to-2027-growing-technological-advancements-are-driving-the-market-researchandmarkets-com/ 2022-10-28T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-bFQznF.jpeg https://medicaex.com/businesswire/global-medical-adhesives-market-to-2027-featuring-h-b-fuller-ashland-cohera-medical-and-arkema-among-others-researchandmarkets-com/ 2022-10-28T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/10/logo-LFWtpJ.jpeg https://medicaex.com/businesswire/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022-3/ 2022-10-28T12:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/10/Harrow_logo_wTag-LQICGU.jpeg https://medicaex.com/businesswire/flare-therapeutics-presents-comprehensive-real-world-data-in-advanced-and-metastatic-urothelial-cancer-in-support-of-therapeutic-targeting-of-pparg-at-2022-eortc-nci-aacr-symposium-2/ 2022-10-28T12:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/10/FlareTx-Logo-OverLightBG-B4iqAS.jpeg https://medicaex.com/businesswire/surmodics-to-report-fourth-quarter-and-fiscal-year-2022-financial-results-on-november-9th-2/ 2022-10-28T12:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/10/Color-logo-zE2P8K.jpeg https://medicaex.com/businesswire/surmodics-to-report-fourth-quarter-and-fiscal-year-2022-financial-results-on-november-9th/ 2022-10-28T12:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/10/Color-logo-6tm3wV.jpeg https://medicaex.com/businesswire/harrow-to-announce-third-quarter-2022-financial-results-on-november-14-2022-2/ 2022-10-28T12:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/10/Harrow_logo_wTag-5yQ7sC.jpeg https://medicaex.com/businesswire/pspnet-families-offering-free-wellbeing-course-for-spouses-of-public-safety-personnel/ 2022-10-28T12:12:02+00:00 https://medicaex.com/wp-content/uploads/2022/10/PSPNET_Families_EN_28129-ahR3CP.jpeg https://medicaex.com/businesswire/nextgen-healthcare-prices-upsized-230-0-million-convertible-senior-notes-offering/ 2022-10-28T11:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/10/NG_Logo_Final_RGB_300-Q2bgCf.jpeg https://medicaex.com/businesswire/avery-dennison-declares-quarterly-dividend/ 2022-10-28T11:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/10/ADH1_Red_1797_less_1-asbvpF.jpeg